Please Note: This trial is no longer enrolling new participants
A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician s Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer (EvoPAR-Prostate01)
Protocol No. | CTO-D9723C00001 | Scope | National |
---|---|---|---|
Principal Investigator | Nabil Adra | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase III |